Susanne A. Schneider

ORCID: 0000-0001-7283-1995
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurological disorders and treatments
  • Genetic Neurodegenerative Diseases
  • Neurological diseases and metabolism
  • Parkinson's Disease Mechanisms and Treatments
  • Metabolism and Genetic Disorders
  • Botulinum Toxin and Related Neurological Disorders
  • Glycogen Storage Diseases and Myoclonus
  • Neurological and metabolic disorders
  • Porphyrin Metabolism and Disorders
  • Lysosomal Storage Disorders Research
  • Hereditary Neurological Disorders
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Autoimmune Neurological Disorders and Treatments
  • Economic and Social Issues
  • RNA regulation and disease
  • Congenital Heart Disease Studies
  • Biochemical and Molecular Research
  • Health and Medical Studies
  • Epilepsy research and treatment
  • Public Administration and Political Analysis
  • Economic and Business Studies
  • Medical and Health Sciences Research
  • Transcranial Magnetic Stimulation Studies
  • Neurogenetic and Muscular Disorders Research

University College London
2008-2024

Ludwig-Maximilians-Universität München
2014-2024

LMU Klinikum
2021-2024

Royal Free London NHS Foundation Trust
2024

General University Hospital in Prague
2024

Royal Manchester Children's Hospital
2024

Comenius University Bratislava
2024

Klinik und Poliklinik für Neurologie
2023

University of Duisburg-Essen
2022

Essen University Hospital
2022

Although many recessive loci causing parkinsonism dystonia have been identified, these do not explain all cases of the disorder.We used homozygosity mapping and mutational analysis in three individuals from two unrelated families who presented with adult-onset levodopa-responsive dystonia-parkinsonism, pyramidal signs cognitive/psychiatric features, cerebral cerebellar atrophy on magnetic resonance imaging but absent iron basal ganglia.We identified areas chromosome 22 and, subsequently,...

10.1002/ana.21415 article EN Annals of Neurology 2008-06-20

Voltage-gated potassium channel complex antibodies, particularly those directed against leucine-rich glioma inactivated 1, are associated with a common form of limbic encephalitis that presents cognitive impairment and seizures. Faciobrachial dystonic seizures have recently been reported as immunotherapy-responsive, brief, frequent events often predate the this encephalitis. However, these observations were made from retrospective study without serial assessments. Here, we undertook first...

10.1093/brain/awt212 article EN Brain 2013-09-06

Paroxysmal dyskinesias are episodic movement disorders that can be inherited or sporadic in nature. The pathophysiology underlying these remains largely unknown but may involve disrupted ion homeostasis due to defects cell-surface channels nutrient transporters. In this study, we describe a family with paroxysmal exertion-induced dyskinesia (PED) over 3 generations. Their PED was accompanied by epilepsy, mild developmental delay, reduced CSF glucose levels, hemolytic anemia echinocytosis,...

10.1172/jci34438 article EN Journal of Clinical Investigation 2008-04-30

In this study, we combined linkage analysis with whole-exome sequencing of two individuals to identify candidate causal variants in a moderately-sized UK kindred exhibiting autosomal-dominant inheritance craniocervical dystonia. Subsequent screening these large number familial and sporadic cases cervical dystonia led the identification total six putatively pathogenic mutations ANO3, gene encoding predicted Ca2+-gated chloride channel that show be highly expressed striatum. Functional studies...

10.1016/j.ajhg.2012.10.024 article EN cc-by The American Journal of Human Genetics 2012-11-29

Neuronal ceroid lipofuscinoses (NCLs) comprise a heterogeneous group of metabolic storage diseases that present with the accumulation autofluorescent lipopigment, neurodegeneration and premature death. Nine genes have been thus far identified as cause different types NCL, ages at onset ranging from around birth to adult, although underlying etiology disease still remains elusive. We family typical NCL pathology in which we performed exome sequencing single homozygous mutation ATP13A2 fully...

10.1093/hmg/dds089 article EN cc-by-nc Human Molecular Genetics 2012-03-02
Catherine S. Storm Demis A. Kia Mona Mohammad Almramhi Sara Bandrés‐Ciga Chris Finan and 95 more Alastair Noyce Rauan Kaiyrzhanov Ben Middlehurst Manuela Tan Henry Houlden Huw R. Morris Hélène Plun‐Favreau Peter Holmans John Hardy Daniah Trabzuni John P. Quinn Vivien J. Bubb Kin Y. Mok Kerri J. Kinghorn Patrick A. Lewis Sebastian R. Schreglmann Ruth C. Lovering Lea R’Bibo Claudia Manzoni Mie Rizig Mina Ryten Sebastian Guelfi Valentina Escott‐Price Viorica Chelban Thomas Foltynie Nigel Williams Karen Morrison Carl E Clarke Kirsten Harvey Benjamin Meir Jacobs Alexis Brice Alexis Brice Suzanne Lesage Jean‐Christophe Corvol María Martínez Claudia Schulte Kathrin Brockmann Javier Simón‐Sánchez Peter Heutink Patrizia Rizzu Manu Sharma Thomas Gasser Susanne A. Schneider Mark Cookson Cornelis Blauwendraat David W. Craig Kimberley Billingsley Mary B. Makarious Derek P. Narendra Faraz Faghri J. Raphael Gibbs Dena Hernández Kendall Van Keuren‐Jensen Joshua Shulman Hirotaka Iwaki Hampton L. Leonard Mike A. Nalls Laurie Robak José Brás Rita Guerreiro Steven Lubbe Timothy Troycoco Steven Finkbeiner Niccoló E. Mencacci Codrin Lungu Andrew Singleton Sonja W. Scholz Xylena Reed Ryan J. Uitti Owen A. Ross Francis P. Grenn Anni Moore Roy N. Alcalay Zbigniew K. Wszołek Ziv Gan‐Or Guy A. Rouleau Lynne Krohn Kheireddin Mufti Jacobus J. van Hilten Johan Marinus Astrid D. Adarmes-Gómez Miquel Aguilar Ignacio Álvarez Victoria Álvarez Francisco Javier Barrero Jesús Alberto Bergareche Yarza Inmaculada Bernal‐Bernal Marta Blázquez Estrada Marta Bonilla‐Toribio Juan A. Botía María Teresa Boungiorno Dolores Buiza‐Rueda Ana Cámara Fátima Carrillo Mario Carrión‐Claro

Parkinson's disease is a neurodegenerative movement disorder that currently has no disease-modifying treatment, partly owing to inefficiencies in drug target identification and validation. We use Mendelian randomization investigate over 3,000 genes encode druggable proteins predict their efficacy as targets for disease. expression protein quantitative trait loci mimic exposure medications, we examine the causal effect on risk (in two large cohorts), age at onset progression. propose 23...

10.1038/s41467-021-26280-1 article EN cc-by Nature Communications 2021-12-20

Abstract We present the clinical details and dopamine transporter SPECT scan results of 10 patients with arm tremor, including a rest component reduced swing on affected side, in whom possibility PD had been raised. All signs dystonia or components their tremor that were compatible dystonic none true akinesia fatiguing decrement, even after mean follow‐up period 5.8 years. normal scans. Clinicians should be aware primary adult‐onset can an asymmetric resting impaired sometimes also facial...

10.1002/mds.21685 article EN Movement Disorders 2007-08-21

Approximately 10% of patients diagnosed clinically with early Parkinson's disease (PD) have normal dopaminergic functional imaging (Scans Without Evidence Dopaminergic Deficit [SWEDDs]). An important subgroup SWEDDs are those asymmetric rest tremor resembling parkinsonian tremor. Clinical and pathophysiological features which could help to distinguish from PD not been explored. We therefore studied clinical details including non-motor symptoms in 25 tremulous comparison tremor-dominant...

10.1002/mds.23019 article EN Movement Disorders 2010-02-03

Abstract Seven autosomal recessive genes associated with juvenile and young‐onset Levodopa‐responsive parkinsonism have been identified. Mutations in PRKN , DJ‐1 PINK1 are a rather pure parkinsonian phenotype, more benign course sustained treatment response absence of dementia. On the other hand, Kufor‐Rakeb syndrome has additional signs, which distinguish it clearly from Parkinson's disease including supranuclear vertical gaze palsy, myoclonic jerks, pyramidal cognitive impairment....

10.1002/mds.23221 article EN Movement Disorders 2010-07-29

The 2 major types of neurodegeneration with brain iron accumulation (NBIA) are the pantothenate kinase type (PANK2)-associated (PKAN) and NBIA2 or infantile neuroaxonal dystrophy (INAD) due to mutations in phospholipase A2, group VI (PLA2G6) gene. We have recently demonstrated clinical heterogeneity patients PLA2G6 gene by identifying a poorly defined subgroup who present late dystonia parkinsonism. report genetic features 7 cases mutations. Brain was available 5 an age death ranging from 8...

10.1016/j.neurobiolaging.2010.05.009 article EN cc-by Neurobiology of Aging 2010-07-11

Dystonia is characterized by two main pathophysiological abnormalities: 'reduced' excitability of inhibitory systems at many levels the sensorimotor system, and 'increased' plasticity neural connections in circuits a brainstem spinal level. A surprising finding recent papers has been fact that abnormalities inhibition similar to those organic dystonia are also seen patients who have psychogenic dystonia. To try determine critical feature might separate conditions, we investigated cortical...

10.1093/brain/awp213 article EN Brain 2009-08-18

Kufor Rakeb disease (KRD, PARK9) is an autosomal recessive extrapyramidal-pyramidal syndrome with generalized brain atrophy due to ATP13A2 gene mutations. We report clinical details and investigational results focusing on radiological findings of a genetically-proven KRD case. Clinically, there was early onset levodopa-responsive dystonia-parkinsonism pyramidal signs eye movement abnormalities. Brain MRI revealed putaminal caudate iron accumulation bilaterally. Our add the group syndromes...

10.1002/mds.22947 article EN Movement Disorders 2010-03-22

The proline-rich transmembrane protein (PRRT2) gene was recently identified using exome sequencing as the cause of autosomal dominant paroxysmal kinesigenic dyskinesia (PKD) with or without infantile convulsions (IC) (PKD/IC syndrome). Episodic neurologic disorders, such epilepsy, migraine, and movement often coexist are thought to have a shared channel-related etiology. To investigate further frequency, spectrum, phenotype PRRT2 mutations, we analyzed this in 3 large series episodic...

10.1212/wnl.0b013e3182752c5a article EN Neurology 2012-10-18

Levodopa induced dyskinesias (LID) are a common problem which ultimately limit the effective treatment of patients with Parkinson's disease (PD). There is accumulating evidence that LID develop due to abnormal synaptic plasticity, in turn influenced by release brain derived neurotrophic factor (BDNF).The influence functional polymorphism BDNF gene on risk developing large cohort PD (n = 315), who were independently and variably treated levodopa and/or other dopaminergic treatments, was...

10.1136/jnnp.2008.154294 article EN Journal of Neurology Neurosurgery & Psychiatry 2008-11-01

Our understanding of the syndromes Neurodegeneration with Brain Iron Accumulation (NBIA) continues to grow considerably. In addition core pantothenate kinase-associated neurodegeneration (PKAN, NBIA1) and PLA2G6-associated (PLAN, NBIA2), several other genetic causes have been identified (including FA2H, C19orf12, ATP13A2, CP FTL). parallel, clinical pathological spectrum has broadened new age-dependent presentations are being described. There is also growing recognition overlap between...

10.2174/157015913804999469 article EN Current Neuropharmacology 2013-01-01
Coming Soon ...